Harmke Bos

Harmke Bos is a researcher at Erasmus MC in the Department of Internal Medicine, focusing on geriatric and clinical outcomes in aging and infectious disease populations. Her work is deeply embedded in large-scale collaborative studies such as the COMET and COOP research groups.

Her research interests center on frailty, comorbidity, geriatric assessment, and aging biomarkers, particularly in the context of hospitalization and infectious diseases like COVID-19. She investigates how clinical tools such as the Clinical Frailty Scale and Charlson Comorbidity Index predict long-term outcomes in elderly patients.

The recent articles reflect a strong trend in clinical epidemiology, geriatric medicine, and metabolomics, with emphasis on risk prediction, cohort analysis, and patient-centered outcomes. Her work often involves multi-center collaborations and contributes to evidence-based practices in geriatric care during pandemics.

Scientific Awards:

• No awards mentioned in the provided text.

Advising and Grants: While no formal students or grants are listed, her involvement in major consortia like COMET and COOP suggests active participation in funded research projects and team-based scientific leadership.

Labs and Teams: Harmke Bos is affiliated with the COMET Research Team and the COOP consortium, both of which conduct large-scale studies on medication use and outcomes in COVID-19 patients, particularly among frail and elderly populations.